share_log

艾德生物:上海荣正企业咨询服务(集团)股份有限公司关于公司2023年限制性股票激励计划首次授予第一个解除限售期解除限售条件成就相关事项之独立财务顾问报告

Ed Biotech: Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. independent financial advisory report on matters relating to the company\'s 2023 restricted stock incentive plan granted the first time to lift the sales restriction period and the achievement of the conditions for lifting the sales restrictions

SZSI ·  Nov 18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more